U.S. Centers for Disease Control and Prevention
Respiratory Diseases Branch, Division of Bacterial Diseases
Dr. Adam L. Cohen is the chief of the bacterial Respiratory Diseases Branch at the U.S. Centers for Disease Control and Prevention. At CDC, Dr. Cohen has worked in the areas of vaccines, child survival, surveillance, antimicrobial resistance, patient safety, global health security, and prevention of pneumonia, influenza, meningitis, and diarrhea in domestic and international settings. He has led and served on national and international committees with the World Health Organization and the United Nations and has authored numerous journal articles and book chapters. He has worked in more than 40 countries and lived and worked at CDC in South Africa and at WHO headquarters in Switzerland. Dr. Cohen started his CDC career as an Epidemic Intelligence Service officer. Dr. Cohen is a pediatrician and received his medical degree from West Virginia University in Morgantown, West Virginia, and completed his residency in pediatrics, fellowship in general academic pediatrics and Master of Public Health degree at the University of Washington in Seattle, Washington. He is board certified in pediatrics, is a Captain in the Commissioned Corps of the U.S. Public Health Service and holds an academic appointment at Emory University.

Moderator Of 3 Sessions

Workshop 04: Epidemiological Data Analysis (2) Evaluating Disease Burden and Vaccine Impact Using Surveillance Data

Session Type
On-site Pre-Symposium Workshop
Date
Sun, 19.06.2022
Session Time
13:00 - 16:00
Room
Grand Ballroom Centre
Session Description
Please note: All ISPPD-12 Workshops are highly interactive and designed to allow at least 25% active learning for the maximum registrants anticipated.
Session Type
Plenary Session
Date
Mon, 20.06.2022
Session Time
09:00 - 10:30
Room
Grand Ballroom East
Session Description
Please note: Each presentation is followed by 5 to 10 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.
Session Type
Parallel Session
Date
Tue, 21.06.2022
Session Time
14:50 - 16:20
Room
Grand Ballroom East
Session Description
Please note: Each presentation is followed by about 3 minutes of Q&A. The audience is encouraged to send questions to the speakers from the beginning of their presentations. Q&A time is included in each speaker’s presentation duration, accounting for at least 25% active learning for the maximum registrants anticipated.